Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.

导出 LinkOut

翻译打印收藏纠错

作者： James,Godfrey ^[1] ; Hongtao,Liu ^[2] ; Jovian,Yu ^[3] ; Michael,Tallarico ^[2] ; Emily,Curran ^[4] ; Andrew,Artz ^[5] ; Peter A,Riedell ^[1] ; Wendy,Stock ^[2] ; Theodore,Karrison ^[3] ; Carrie,Fitzpatrick ^[2] ; Girish,Venkataraman ^[3] ; Alan,Cooper ^[6] ; Sonali M,Smith ^[7] ; Michael R,Bishop ^[8] ; Justin,Kline ^[2]

作者单位： Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA. ^[1] Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL. ^[2] David and Etta Jones Center for Cellular Therapy, University of Chicago, Chicago, IL. ^[3] Northwest Oncology, Dyer, IN. ^[4] Division of Hematology/Oncology, College of Medicine, University of Cincinnati, Cincinnati, IL. ^[5] Department of Public Health Sciences, University of Chicago, Chicago, IL. ^[6] Department of Cytogenetics, University of Chicago, Chicago, IL. ^[7] Department of Pathology, University of Chicago, Chicago, IL. ^[8]

主题词人类(Humans);动物(Animals);小鼠(Mice);前瞻性研究(Prospective Studies);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);复发(Recurrence);霍奇金病(Hodgkin Disease)

DOI 10.1182/bloodadvances.2022008403

PMID 35973200

发布时间 2023-03-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood advances

2023年7卷6期

963-970页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.

Blood advances

相似文献

Blood advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.

Blood advances

相似文献

Blood advances

相关期刊

检索历史清除